COMPANY
About Us
Oncoscience GmbH specialises in researching and developing new therapeutic approaches for rare diseases and complex medical challenges. As part of the Innokeys Pte Ltd Group, we focus on precise diagnostic procedures and advanced technologies. Our goal is to advance scientific knowledge and contribute to the optimisation of treatment strategies in these specialised areas.
Who we are
We are a company in the field of biotechnology and pharmaceutical research. Our focus is on the development of orphan drugs and targeted therapeutic approaches for rare diseases and tumour types. Through our collaboration with Innokeys Pte Ltd, we benefit from a global network of resources and expertise.
Our aim is to research and develop scientifically sound therapeutic approaches to provide new options for patients with limited treatment alternatives. We rely on evidence-based research and dialogue with the medical community to develop more precise and effective strategies.
Our Approach
We focus on the research and development of new therapeutic approaches for diseases with a high medical need. We place particular emphasis on precise diagnostic procedures and targeted treatment strategies that are designed to be as customised and tolerable as possible
Our areas of specialisation include:
1. Rare diseases:
Research and development of new therapeutic approaches for rare diseases with the aim of expanding scientific knowledge and investigating new treatment strategies.
2. Precision medicine:
Research into targeted therapeutic approaches that investigate the molecular and genetic mechanisms of diseases in order to gain new scientific insights.
3. Diagnostic technologies:
Research and development of diagnostic technologies with the aim of investigating new approaches for the detection and characterisation of difficult-to-treat tumours.
4. Immo-oncology:
Research into the mechanisms of the immune system with a view to developing new scientific concepts in immuno-oncology.
Our Influence
We work closely with research institutes, medical institutions and pharmaceutical partners to advance the research and development of innovative therapeutic approaches. Our collaborations aim to promote scientific exchange on potential new treatment approaches.
By utilising global resources and scientific expertise, we contribute to orphan drug research. We see ourselves as part of a comprehensive network that is working to gain new scientific insights into rare and complex diseases.
Collaboration
We invite medical professionals to exchange ideas with us about research into new scientific concepts for rare diseases. If you are interested in a professional exchange or would like to find out more about our projects, we look forward to hearing from you.
Note: This text is intended for healthcare professionals only and is not intended for the general public or patients. Statements on medicines or treatments are based on current scientific knowledge and require individual advice from qualified medical professionals.